ChihiroMorishimaMD

PubMed

• 1 citations
  Copper deficiency is an independent risk factor for mortality in patients with advanced liver disease.
  Lei Yu, Sarim Yousuf, Shahrukh Yousuf, Jeffrey Yeh, Scott W Biggins, Chihiro Morishima, Irene Shyu, Galen O'Shea-Stone, Brian Eilers, Annie Waldum, Valérie Copié, Jaso...> ;Hepatology Communications. 2023 Mar 1
• 5 citations
  Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
  Yevgeniy Yuzefpolskiy, Peter Morawski, Mitch Fahning, Cate Speake, Sandra Lord, Anu Chaudhary, Chihiro Morishima, Mark H Wener, Mariko Kita, Lucas McCarthy, Jane H Buc...> ;Journal of Immunology. 2022 Apr 1
• 26 citations
  Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
  Kunle Odunsi, Feng Qian, Amit A Lugade, Han Yu, Melissa A Geller, Steven P Fling, Judith C Kaiser, Andreanne M Lacroix, Leonard D'Amico, Nirasha Ramchurren, Chihiro Mo...> ;Science Translational Medicine. 2022 Mar 16
• Anti-Nuclear Antibody Quantitation: Calibration and Harmonization Adjustment via Population Interrogation.
  Mark H Wener, Susan L Fink, Chihiro Morishima, Anu Chaudhary, Kathleen Hutchinson> ;The Journal of Applied Laboratory Medicine. 2022 Jan 5
• 16 citations
  New interpretable machine learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy
  Evan Greene, Greg Finak, Leonard A D'Amico, Nina Bhardwaj, Candice D. Church, Chihiro Morishima, Nirasha Ramchurren, Janis M. Taube, Paul Nghiem, Martin A. Cheever, St...> ;Patterns. 2021 Oct 27
• 31 citations
  Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing.
  Tess Hendelman, Anu Chaudhary, Angela Leclair, Kimberly van Leuven, Jacqueline Chee, Susan L. Fink, Emily J. Welch, Erwin Berthier, Brook A Quist, Anna Wald, Mark H. W...> ;Plos One. 2021 Sep 2
• 37 citations
  Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Ste...
  Benjamin T. Bradley, Andrew Bryan, Susan L. Fink, Erin A. Goecker, Pavitra Roychoudhury, Meei-Li Huang, Haiying Zhu, Anu Chaudhary, Bhanupriya Madarampalli, Joyce Y C ...> ;Journal of Clinical Microbiology. 2021 Aug 18
• 32 citations
  IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
  Russell K. Pachynski, Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard Joseph Appleman, Paul Monk, Rhonda L. Bitting, Omer Kucuk, Frederick Millar...> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• 3 citations
  Correspondence on SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al ."
  Sarah H. Chung, Mark H. Wener, Alison M. Bays, Habib Rahbar, Chihiro Morishima, Andrew Bryan, Susan L. Fink, Seth M. Cohen, Nandita S Mani, Anu Chaudhary, Gregory C. G...> ;Annals of the Rheumatic Diseases. 2021 Jul 31
• 56 citations
  Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
  Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E Shapiro, Victoria L. Campbell, Christopher L. McClurkan, Lichen ...> ;The Journal of Clinical Investigation. 2021 Feb 1
• 52 citations
  Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
  Nina Bhardwaj, Philip Friedlander, Anna C. Pavlick, Marc S. Ernstoff, Brian R. Gastman, Brent A. Hanks, Brendan D. Curti, Mark R. Albertini, Jason J. Luke, Ana Belen B...> ;Nature Cancer. 2020 Nov 16
• 28 citations
  SARS-CoV-2 viral load on admission is associated with 30-day mortality
  Andrew Bryan, Susan L. Fink, Meghan A Gattuso, Gregory Pepper, Anu Chaudhary, Mark H. Wener, Chihiro Morishima, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greni...> ;Open Forum Infectious Diseases. 2020 Nov 3
• 4 citations
  Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19
  Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E Shapiro, Victoria L. Campbell, Christopher L. McClurkan, Lichen ...> ;Medrxiv. 2020 Oct 8
• 9 citations
  Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.
  Marie K. Das, Anu Chaudhary, Andrew Bryan, Mark H. Wener, Susan L. Fink, Chihiro Morishima> ;Emerging Infectious Diseases. 2020 Jul 29
• 253 citations
  Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
  Peter D. Burbelo, Francis X. Riedo, Chihiro Morishima, Stephen A. Rawlings, Davey M. Smith, Sanchita Das, Jeffrey R Strich, Daniel S. Chertow, Richard T. Davey, Jeffre...> ;The Journal of Infectious Diseases. 2020 Jun 29
• 417 citations
  Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
  Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L. Fink, Chihiro Morishima, Anu Chaudhary, Keith R. Jerome, Patrick C. Mathias, Alexander L. Greninger> ;Journal of Clinical Microbiology. 2020 Jul 23
• 98 citations
  Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.
  Peter D. Burbelo, Francis X. Riedo, Chihiro Morishima, Stephen A. Rawlings, Davey M. Smith, Sanchita Das, Jeffrey R Strich, Daniel S. Chertow, Richard T. Davey, Jeffre...> ;Medrxiv. 2020 Apr 24
• 49 citations
  Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19).
  L. Angelica Lerma, Anu Chaudhary, Andrew Bryan, Chihiro Morishima, Mark H. Wener, Susan L. Fink> ;Journal of Translational Autoimmunity. 2020 Nov 27
• 30 citations
  Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
  Minjun C. Apodaca, Amy Wright, Angela M. Riggins, William P. Harris, Raymond S. Yeung, Lei Yu, Chihiro Morishima> ;Journal for Immunotherapy of Cancer. 2019 Aug 28
• 122 citations
  Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.
  Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, Jeffrey S. Miller, Sylvia Lee, Ann W. Silk, Shernan G. Holtan, Andreanne M. Lacroix, Steven P. Fling, Judith C Kai...> ;Clinical Cancer Research. 2018 Nov 15
• 81 citations
  Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.
  Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton, Christina S. Baik, Bernardo H. L. Goulart, Leslie N. Anderson, Kristi Manjarrez, Gregory N. Dietsch, James Kyle Bry...> ;Clinical Cancer Research. 2017 May 15
• 104 citations
  Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study
  Kelly G. Paulson, C. Lewis, Mary W. Redman, William T. Simonson, Aaron Lisberg, Deborah I. Ritter, Chihiro Morishima, Kathleen Hutchinson, Lola Mudgistratova, Astrid B...> ;Cancer. 2017 Apr 15
• 116 citations
  A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
  Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish R. Patel, Holbrook E Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary L. Disis, Judith...> ;Clinical Cancer Research. 2017 Dec 4
• 48 citations
  A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen
  Brenna C. Simons, Philip R. Spradling, Dana J. T. Bruden, Carolyn Zanis, Samantha Case, Tammy L. Choromanski, Minjun C. Apodaca, Hazel D. Brogdon, Gaelen K. Dwyer, Mar...> ;The Journal of Infectious Diseases. 2016 Jul 15
• 43 citations
  Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
  Gregory N. Dietsch, Hailing Lu, Yi Yang, Chihiro Morishima, Laura Qm Chow, Mary L. Disis, Robert M. Hershberg> ;Plos One. 2016 Feb 29
• Join now to see all

Journal Articles

• Phase I Trial of ALT-803, a Novel Recombinant Interleukin-15 Complex, in Patients with Advanced Solid Tumors  
  Jeffrey S Miller, Shernan G Holtan, Sylvia M Lee, Chihiro Morishima, Ann W Silk, Clinical Cancer Research